Creating a New Therapy (IND Submission)

IND Submission: Asking for Permission

凯时手机版appAt the end of all of this work, the developers think that the drug is ready to be tested in humans.

凯时手机版appThey can make it in a uniform manner in a form that can be given to people. They know a range of doses that are predicted to be safe in humans, and know that there are doses in this range that would be expected to have a therapeutic effect. They know how to administer the drug to participants and what markers to look for to see if it is having an effect. They have a feasible trial design, patients who want to take part and clinicians willing to run the trial.

At this point, the developer has the data that is needed to ask the FDA for approval to move forward.

凯时手机版appIf all this data is approved by the FDA, the drug will be allowed to start trials. That’s when it gets exciting — what happens to the drug in a human being? Will it work?

Next: Clinical Trial
凯时国际官网app下载 凯时kb88手机版app 凯时娱人生就是博乐app 凯时国际下载 凯时官网线路 凯时主页 凯时kb88app 凯时真人娱乐登录